RO6807952

RO6807952 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RO6807952, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO6807952 in Patients With Diabetes Mellitus Type 2 [Phase 1]